| ID | JOS-j.biopha.2023.115940 |
| 著者:名前 | |
| 著者:別形式 | Kiba, Yuka / Tanikawa, Takashi / Hayashi, Tsuyoshi / Kamauchi, Hitoshi / Seki,Taishi / Suzuki, Ryuichiro / Kitamura , Masashi |
| 著者:カナ | |
| 著者:所属 | 城西大学薬学部薬学科 / 城西大学薬学部薬学科 / 国立感染症研究所ウイルス第二部 / 城西大学薬学部薬科学科 / 城西大学薬学部薬学科 / 城西大学薬学部薬科学科 / 城西大学薬学部薬学科 |
| 著者:所属(別形式) | Josai University, Faculty of Pharmacy and Pharmaceutical Sciences, School of Pharmacy / Josai University, Faculty of Pharmacy and Pharmaceutical Sciences, School of Pharmacy / National Institute of Infectious Diseases, Department of Virology II / Josai University, Faculty of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences / Josai University, Faculty of Pharmacy and Pharmaceutical Sciences, School of Pharmacy / Josai University, Faculty of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences / Josai University, Faculty of Pharmacy and Pharmaceutical Sciences, School of Pharmacy |
| 著者版フラグ | publisher |
| 出版地 | Amsterdam |
| 出版者 | Elsevier |
| 冊子ISSN | 07533322 |
| 掲載誌名 | |
| 巻 | 169 |
| 刊行年月 | 2023-12 |
| 開始ページ | 1 |
| 終了ページ | 6 |
| コンテンツ作成日 | 2023-09-11 |
| コンテンツ修正日 | 2023-11-21 |
| コンテンツ登録日 | 2023-12-25 |
| 識別番号:DOI | info:doi/10.1016/j.biopha.2023.115940 |
| 識別番号:DOI(リンク) | |
| PubMed番号 | 38007936 |
| 抄録 | Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread as a pandemic and caused damage to people’s lives and countries’ economies. The spike (S) protein of SARS-CoV-2 contains a cleavage motif, Arg-X-X-Arg, for furin and furin-like enzymes at the boundary of the S1/S2 subunits. Given that cleavage plays a crucial role in S protein activation and viral entry, the cleavage motif was selected as the target. Our previous fluorogenic substrate study showed that osthole, a coumarin compound, inhibits furin-like enzyme activity. In this study, we examined the potential activities of 15 compounds with a structure-activity relationship with osthole, and evaluated their protective ability against SARS-CoV-2 infection. Of the 15 compounds tested, compounds C1 and C2 exhibited the inhibitory effects of osthole against furin-like enzymatic activity; however, little or no inhibitory effects against furin activity were observed. We further examined the inhibition of SARS-CoV-2 activity by compounds C1 and C2 using a Vero E6 cell line that expresses the transmembrane protease serine 2 (TMPRSS2). Compounds C1, C2, and osthole effectively inhibited SARS-CoV-2 infection. Therefore, osthole and its derivatives can potentially be used as therapeutic agents against SARS-CoV-2. |
| キーワード | |
| 注記 | Article number: 115940 (2023) Published by Elsevier Masson SAS. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| 言語 | eng |
| 資源タイプ | text |
| ジャンル | |
| フォーマット | application/pdf |
| 権利 | Copyright © 2023 The Author(s). |
| このアイテムを表示する:本文(pdf) |  ダウンロード回数: 回 |
| このアイテムを表示する:URI | |